Is Innovent Biologics Inc stock a buy?

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Innovent Biologics Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $3.43, you would have made a profit of $1.660 per share or 48.40%

No, the average daily trading liquidity for Innovent Biologics Inc is $8 696 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Innovent Biologics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.01, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Innovent Biologics Inc to be high [0.75 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.